The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Relievant MedSystems sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Relievant MedSystems Inc, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Relievant MedSystems Inc (Relievant) operates as a medical device company that develops new minimally-invasive solutions for the treatment of chronic low back pain (CLBP). The company’s Intracept system, a minimally invasive procedure uses radiofrequency energy delivered through a small access tube into the targeting the basivertebral nerve for the relief of chronic low back pain, vertebral body,. It serves orthopedic surgeons, neurological surgeons and interventionalists. Relievant has its research and development and operations facility in Sunnyvale, California. The company is funded by Endeavour Vision SA, Richard King Mellon Foundation, New Enterprise Associates, Canaan Ventures, Morgenthaler, and Emergent Ventures. Relievant is headquartered in Minneapolis, Minnesota, the US.

The key metrics of Relievant MedSystems related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Relievant MedSystems is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Relievant MedSystems.

For a detailed understanding of the performance of Relievant MedSystems, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.